Henry N. Ginsberg, MD, is the Irving Professor of Medicine at Columbia University College of Physicians and Surgeons and Director of the Irving Institute for Clinical and Translational Research at Columbia University Medical Center in New York, New York.  He is also the Principal Investigator of one of the first 12 NIH–funded Clinical Translational Science Awards (CTSA). Dr. Ginsberg earned his medical degree at the State University of New York Downstate Medical Center in Brooklyn, and completed training in internal medicine in the Boston University Service of the Boston City Hospital in Massachusetts. Dr. Ginsberg also trained in endocrinology and metabolism at Stanford University in California.

        Dr. Ginsberg is principal investigator on two R01 research grants from the NIH, National Heart, Lung, and Blood Institute.  He is also the co-principal investigator at Columbia on the ACCORD Trial.  His research interests have focused on the regulation of plasma cholesterol and triglyceride blood levels, particularly the metabolism of apolipoprotein B–containing lipoproteins in cells, mice, and humans. Much of his present work focuses on the interaction between insulin resistance and increased secretion of very low-density lipoproteins by the liver. Very active in clinical research training and education, Dr. Ginsberg is also program director of a T32 Postdoctoral Training Grant in Arteriosclerosis.  The CTSA includes a predoctoral T32 program in translational research, a master’s degree program in patient oriented research, and a junior faculty K12 Clinical Research Scholars Program.
 
        Dr. Ginsberg actively participates in national organizations such as the American Heart Association (AHA) and the American Diabetes Association. He is a Fellow of the AHA Council on Arteriosclerosis, Thrombosis and Vascular Biology, and past chair of the AHA Leadership Committee. He is also a Fellow of the AHA Council on Nutrition, Physical Activity and Metabolism, a Fellow of the American Association for the Advancement of Science, as well as a member of the American Society for Clinical Investigation and the Association of American Physicians. Dr Ginsberg is on the editorial boards of The Journal of Clinical Investigation, Journal of Lipid Research, and Journal of Metabolism. He has authored or coauthored more than 200 articles, reviews, and chapters related to lipids, diabetes, and heart disease.